4.7 Article

Alzheimer's disease heterogeneity explained by polygenic risk scores derived from brain transcriptomic profiles

Related references

Note: Only part of the references are listed.
Article Multidisciplinary Sciences

Sequencing of 53,831 diverse genomes from the NHLBI TOPMed Program

Daniel Taliun et al.

Summary: The TOPMed program aims to study the genetic architecture and biology of heart, lung, blood, and sleep disorders to improve diagnosis, treatment, and prevention of these diseases. Resources include a variant browser, genotype imputation server, and genomic and phenotypic data available through dbGaP. The study detected a large number of rare genetic variants, providing insights into mutation processes and recent human evolutionary history.

NATURE (2021)

Article Multidisciplinary Sciences

Improving reporting standards for polygenic scores in risk prediction studies

Hannah Wand et al.

Summary: Polygenic risk scores (PRSs) aggregate results from genome-wide association studies to estimate disease risk, but heterogeneity in their application and reporting hinders translation into clinical care. To address this, Polygenic Risk Score Reporting Standards (PRS-RS) have been proposed, providing a comprehensive framework to enhance the interpretation and evaluation of PRSs for downstream clinical applications. This structured format aims to promote data availability, transparency, and reproducibility, facilitating the progress towards defining best practice in the field.

NATURE (2021)

Article Biochemistry & Molecular Biology

Integrative brain transcriptome analysis links complement component 4 and HSPA2 to the APOE epsilon 2 protective effect in Alzheimer disease

Rebecca Panitch et al.

Summary: The study found that the protective effect of APOE ε2 against Alzheimer's disease may be related to the complement pathway, involving genes such as C4A, C4B, and HSPA2. An AD-specific co-expression network was identified in APOE ε2/ε3 carriers, primarily associated with tau pathology.

MOLECULAR PSYCHIATRY (2021)

Article Neuroimaging

Differential patterns of gray matter volumes and associated gene expression profiles in cognitively-defined Alzheimer's disease subgroups

Colin Groot et al.

Summary: In this study, differences in regional gray matter volumes and gene expression profiles were compared between cognitively-defined subgroups of individuals with AD, revealing neurobiological distinctions associated with each subgroup's cognitive profile. These findings suggest that distinct biological pathways may contribute to the emergence of cognitive heterogeneity in AD.

NEUROIMAGE-CLINICAL (2021)

Article Biochemistry & Molecular Biology

Genetic data and cognitively defined late-onset Alzheimer's disease subgroups

Shubhabrata Mukherjee et al.

MOLECULAR PSYCHIATRY (2020)

Article Clinical Neurology

Language and spatial dysfunction in Alzheimer disease with white matter thorn-shaped astrocytes

Elisa de Paula Franca Resende et al.

NEUROLOGY (2020)

Review Genetics & Heredity

Genetic Influences on Disease Subtypes

Andy Dahl et al.

ANNUAL REVIEW OF GENOMICS AND HUMAN GENETICS, VOL 21, 2020 (2020)

Article Multidisciplinary Sciences

Interpreting molecular similarity between patients as a determinant of disease comorbidity relationships

Jon Sanchez-Valle et al.

NATURE COMMUNICATIONS (2020)

Article Clinical Neurology

Polygenic risk and hazard scores for Alzheimer's disease prediction

Ganna Leonenko et al.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2019)

Article Multidisciplinary Sciences

Single-cell transcriptomic analysis of Alzheimer's disease

Hansruedi Mathys et al.

NATURE (2019)

Article Clinical Neurology

Genome-wide association study of Alzheimer's disease endophenotypes at prediagnosis stages

Jaeyoon Chung et al.

ALZHEIMERS & DEMENTIA (2018)

Article Multidisciplinary Sciences

A multi-omic atlas of the human frontal cortex for aging and Alzheimer's disease research

Philip L. De Jager et al.

SCIENTIFIC DATA (2018)

Editorial Material Medicine, General & Internal

Why do so many clinical trials of therapies for Alzheimer's disease fail?

Roy M. Anderson et al.

LANCET (2017)

Article Clinical Neurology

Polygenic Risk Score Analysis of Pathologically Confirmed Alzheimer Disease

Escott-Price Valentina et al.

ANNALS OF NEUROLOGY (2017)

Article Clinical Neurology

The identification of cognitive subtypes in Alzheimer's disease dementia using latent class analysis

Nienke M. E. Scheltens et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2016)

Article Endocrinology & Metabolism

Expanding the Clinical Spectrum Associated With GLIS3 Mutations

P. Dimitri et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)

Article Multidisciplinary Sciences

A survey of human brain transcriptome diversity at the single cell level

Spyros Darmanis et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)

Editorial Material Neurosciences

The role of astrocytes in amyloid β-protein toxicity and clearance

Dietmar Rudolf Thal

EXPERIMENTAL NEUROLOGY (2012)

Article Endocrinology & Metabolism

Novel GLIS3 mutations demonstrate an extended multisystem phenotype

P. Dimitri et al.

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2011)

Article Biochemical Research Methods

WGCNA: an R package for weighted correlation network analysis

Peter Langfelder et al.

BMC BIOINFORMATICS (2008)

Review Biochemistry & Molecular Biology

Vitamin E and neurodegenerative diseases

Roberta Ricciarelli et al.

MOLECULAR ASPECTS OF MEDICINE (2007)